Fig. 10.1 Adaptive tolerance based stereotactic body radiotherapy dose prescription, showing a graphical depiction of the relationship between the duodenum and pancreatic tumor (red) that is used to determine each…
Fig. 17.1 Representative treatment plan of recurrent soft tisuue sarcoma SBRT reirradiation using the CyberknifeTM technique 17.7 Toxicity Patients will need to be monitored during the treatment course with documentation…
Study n of patients Median dose/n of fraction Median (range) follow-up, months Local control rate Overall survival Toxicity Onimaru et al. [51] 45 48 Gy/8; 60 Gy/8 18 (2–44) 3-years,…
Fig. 7.1 A 81 year old man with painful spine metastases at T6 and T7 of metastatic melanoma as demonstrated on sagittal MRI (a) and sagittal CT treatment plan (b)….
© Springer-Verlag London 2015Andrew Gaya and Anand Mahadevan (eds.)Stereotactic Body Radiotherapy10.1007/978-0-85729-597-2_1 1. Introduction to Stereotactic Body Radiotherapy Andrew M. Gaya1 and Anand Mahadevan2 (1) Department of Clinical Oncology, Guy’s Hospital, Guy’s & St. Thomas’ NHS Foundation Trust, London,…
© Springer-Verlag London 2015Andrew Gaya and Anand Mahadevan (eds.)Stereotactic Body Radiotherapy10.1007/978-0-85729-597-2_2 2. History and the Technological Evolution of Stereotactic Body Radiotherapy Dharanipathy Rangaraj1 and Lech S. Papiez2 (1) Department of Radiation Oncology, Baylor Scott & White Health, Temple,…
Author (year) N Total dose (Gy) Daily dose (Gy) Reference point Local control Median follow-up Arimoto et al. (1998) [3] 24 60 7.5 Isocenter 92 % (not described) 24 months Uematsu et…
Fig. 18.1 Illustrative explanation of the image based phase recognition using NCC between adjacent projections in a limited area (yellow box), which is shifted along with the cranio-caudal axis on…
